InVivo Therapeutics Holdings Corp. (NVIV) announced the appointment of Jeffrey Hatfield to its Board of Directors. Mr. Hatfield most recently served as President, Chief Executive Officer, and Board Member for Vitae Pharmaceuticals and served in those capacities since joining the company in March 2004. He is currently a member of the Board of Directors of the Biotechnology Industry Organization (BIO), serving on the Executive Committee of the Emerging Company Section. He is also a member of the advisory committees for Purdue University’s College of Pharmacy, Drexel University’s LeBow College of Business, and the Chapman-KGI School of BioPharmacy.